Top

Publications list

Area

Group

Year

Disease

Text

Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted setting.

Cellular Therapy & Immunobiology Working Party (CTIWP)

1st listed author

Bone Marrow Transplant.

Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT.

Cellular Therapy & Immunobiology Working Party (CTIWP)

1st listed author

Bone Marrow Transplant.

Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT.

Transplant Complications Working Party (TCWP)

1st listed author

Bone Marrow Transplant.

Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT.

Transplant Complications Working Party (TCWP)

1st listed author

Biol Blood Marrow Transplant.

Ocular graft-versus-host disease after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT.

Transplant Complications Working Party (TCWP)

1st listed author

Biol Blood Marrow Transplant.

Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia - a matched pair analysis by the Acute Leukaemia Working Party of EBMT.

Acute Leukemia Working Party (ALWP)

1st listed author

Evaluation of Second Solid Cancers After Hematopoietic Stem Cell Transplantation in European Patients.

Transplant Complications Working Party (TCWP)

1st listed author

High-risk chronic lymphocytic leukemia in the era of pathway inhibitors: integrating molecular and cellular therapies.

Chronic Malignancies Working Party (CMWP)

1st listed author

Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT.

Chronic Malignancies Working Party (CMWP)

1st listed author

Bone Marrow Transplant.

Family mismatched allogeneic stem cell transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of EBMT.

Chronic Malignancies Working Party (CMWP)

1st listed author

Biol Blood Marrow Transplant.

Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT.

Chronic Malignancies Working Party (CMWP)

1st listed author

Outcomes of Haploidentical Transplantation in Patients with Relapsed Multiple Myeloma: An EBMT/CIBMTR Report.

Chronic Malignancies Working Party (CMWP)

1st listed author

Biol Blood Marrow Transplant.

Need help?

First Name

Last Name

Email address

CIC number

Area of interest

Message box

I understand and accept that my personal data will be used for communication concerning the submitted query or request.

The personal data provided will be processed according to the General Data Protection Regulation (GDPR 2016/679 ) and incorporated to a file property of EBMT which will be allocated in the EEA (European Economic Area) or in countries that are provided with the same level of protection for privacy such as countries that adhere to EU-US and Swiss-US Privacy Shield Frameworks.
Data Subjects have the right of access to his or her data and the right to rectification of any inaccurate or incomplete personal data. The Data Subject also has the right to withdraw consent, this wish will be respected, and the personal will no longer be made available. If the processing operation is unlawful the Data Subject has the right to request deletion of that data. Please write to data.protection@ebmt.org